utilizing the notch1 pathway in cll treatment
Published 4 years ago • 347 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
1:37
utilizing the notch1 pathway in the treatment of cll
-
2:05
the role of notch1 mutation in cll
-
1:29
the importance of treatment sequencing in cll
-
0:45
key trials in cll and designing a concept for treatment
-
1:09
cll treatment: discussing new data from the last 3 years
-
13:19
ighv and tp53 sequencing: clinical utility in chronic lymphocytic leukemia (cll)
-
11:30
cll patient story - diane george
-
21:06
lymphoid series part 1
-
4:25
cll: state of the art in italy
-
2:40
chromatin activation underlying pathogenic mechanisms in mm & cll
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
1:20
improving outcomes of non-covalent btki treatment
-
2:20
treatment approaches for mutated and unmutated cll
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
4:17
altered pathways as a biomarker for disease outcomes in cll
-
3:34
the incidence and clinical correlates of non-immune cytopenia at cll diagnosis
-
2:02
key questions about the future of cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
4:38
venice i: venetoclax in r/r cll patients
-
2:15
cd8 t cell expansion in cll patients treated with ibrutinib
-
1:18
the impact of the approval of pirtobrutinib on the treatment landscape for patients with cll